GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Book Value per Share

CollPlant Biotechnologies (CollPlant Biotechnologies) Book Value per Share : $2.13 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Book Value per Share?

CollPlant Biotechnologies's book value per share for the quarter that ended in Mar. 2024 was $2.13.

During the past 12 months, CollPlant Biotechnologies's average Book Value Per Share Growth Rate was -18.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 56.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 28.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 24.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of CollPlant Biotechnologies was 131.60% per year. The lowest was -30.00% per year. And the median was 24.25% per year.

CollPlant Biotechnologies's current price is $5.605. Its book value per share for the quarter that ended in Mar. 2024 was $2.13. Hence, today's PB Ratio of CollPlant Biotechnologies is 2.63.

During the past 12 years, the highest P/B Ratio of CollPlant Biotechnologies was 4.85. The lowest was 1.46. And the median was 2.50.


CollPlant Biotechnologies Book Value per Share Historical Data

The historical data trend for CollPlant Biotechnologies's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Book Value per Share Chart

CollPlant Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.64 4.19 2.89 2.48

CollPlant Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.63 3.16 2.83 2.48 2.13

Competitive Comparison of CollPlant Biotechnologies's Book Value per Share

For the Biotechnology subindustry, CollPlant Biotechnologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's PB Ratio falls into.



CollPlant Biotechnologies Book Value per Share Calculation

CollPlant Biotechnologies's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(28.34-0.00)/11.45
=2.47

CollPlant Biotechnologies's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(24.45-0.00)/11.45
=2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


CollPlant Biotechnologies  (NAS:CLGN) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


CollPlant Biotechnologies Book Value per Share Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.